Login
$LTRN
$0.64 +$0.02 (2.6%) Close

Ownership

13F as of Q2 2026 · 12.8M shares outstanding

Who owns LTRN?

By type of holder
Institutions 22.4% Insiders 19.7% Everyone else 57.9%
Concentration Top 10 holders own 40.5%
BIOS Capital Management, LP 2.0% · Empery Asset Management, LP 6.6%
Institutional ownership
22.4%
+6.0 pts vs last qtr
Institutional holders
38
+5 vs last qtr
Net shares bought
+772.1K
by institutions in Q2 2026
New / sold out
11 / 6
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026
  • Empery Asset Management, LP NEW +842.7K
  • CM Management, LLC +250.0K

Sign up to see all 5.

Biggest sellers in Q2 2026
  • BIOS Capital Management, LP −615.0K
  • Voss Capital, LP SOLD OUT −50.0K

Sign up to see all 5.

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Lantern Pharma Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2022–FY2025
+0.4%
+0.15% a year
Each share's claim on the business
−0.4%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
$2.98M vs $3.51M
over 4 fiscal years
Diluted shares, split-adjusted
10.4M10.7M11.0M2022: 10.9M shares'222023: 10.8M shares'232024: 10.8M shares'242025: 10.9M shares'25
Buybacks Stock-based comp
$0$1.2M$2.5M2022 buybacks: $2.5M2022 stock comp: $1.2M'222023 buybacks: $500.0K2023 stock comp: $1.0M'232024 buybacks: $02024 stock comp: $652.0K'242025 buybacks: $02025 stock comp: $651.0K'25

How patient are the owners?

Institutional shares by how long they've been held
5+ years24% 3–5 years29% 1–3 years12% Under 1 year35%
Quarterly turnover
53.2%
of institutional shares changed hands
Top 10 managers, median time held
4.3 years

Super Investors

Investment managers reporting LTRN on Form 13F
BC
BIOS Capital Management, LP
13D · 4.5%
Shares
249.4K
% of company
1.95%
Change vs last qtr
−615.0K (−71.1%)
Held since
2024
EA
Empery Asset Management, LP
Shares
842.7K
% of company
6.59%
Change vs last qtr
NEW
Held since
Q2 '26

28 more super investors behind a free account

See every manager holding Lantern Pharma Inc, how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting LTRN on Form N-PORT; together they hold 4.6% of the company
VT
Position value
$1.41M
% of company
2.65%
% of the fund
0.00%
As of
June 30, 2026
VE
Position value
$338K
% of company
0.63%
% of the fund
0.00%
As of
June 30, 2026

13 more funds behind a free account

See every fund holding Lantern Pharma Inc and how much of the fund the position is.

Sign up free

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G
LW
Leslie W. Kreis
5%+ holder13D · 4.5%
Shares
571.3K
% of company
4.47%
Change vs last qtr
—
Held since
—
CA
Cavu Advisors, LLC
5%+ holder13D · 4.5%
Shares
571.3K
% of company
4.47%
Change vs last qtr
—
Held since
—

11 more holders behind a free account

See every insider and 5%+ holder of Lantern Pharma Inc.

Sign up free

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support